Skip to main content
SpringerLink
Log in

Personalised medicine has large potential for all stakeholders

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The report was developed with and supported by Amgen, Roche, GE Healthcare and the Association of the British Pharmaceutical Industry.

Reference

  • Academy of Medical Sciences. Realising the potential of stratified medicine. Internet Document : Jul 2013. Available from: URL: www.acmedsci.ac.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Personalised medicine has large potential for all stakeholders. PharmacoEcon Outcomes News 683, 3 (2013). https://doi.org/10.1007/s40274-013-0564-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0564-6

Search

Navigation